Bonvini Ezio reported option exercise involving 40,000 shares of MACROGENICS INC at $2.60 for $104k on Aug 17, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Sr VP, Research & CSO
Sr VP, Research & CSO
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$104,000Shares × reported price
Shares traded
40,000Common Stock
Price per share
$2.60Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
185,799Direct
Trade date
Aug 17, 2026Option exercise
Filed
Aug 18, 2026, 4:19 PM ET1-day reporting delay
Accession
0001588365-26-000007Code M · Transaction 2272
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Option exercise40,000$2.60−$104,000Trade 2273
2 transaction rows in this filing. Joint filers share the same rows.

MGNX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MGNX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago −6.6%1d ago −6.6%
Returns since7d +2%30d +1%90d −46%180d1y

Footnotes in full

F1: The transaction represents an exercise and hold of options. F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.